Author:
Tabata K,Kurosaka S,Watanabe M,Edamura K,Satoh T,Yang G,Abdelfattah E,Wang J,Goltsov A,Floryk D,Thompson T C
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,Molecular Medicine
Reference42 articles.
1. Jemal A, Siegel R, Xu J, Ward E . Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277–300.
2. Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004; 351: 1502–1512.
3. Vogelstein B, Kinzler KW . p53 function and dysfunction. Cell 1992; 70: 523–526.
4. Che M, DeSilvio M, Pollack A, Grignon DJ, Venkatesan VM, Hanks GE et al. Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202. Int J Radiat Oncol Biol Phys 2007; 69: 1117–1123.
5. Thompson TC, Timme TL, Sehgal I . Oncogenes, growth factors and hormones in prostate cancer. In: Dickson RB, Salomon SD (eds). Hormones and Growth Factors in Development and Neoplasia. John Wiley and Sons: New York, 1998.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献